Literature DB >> 20039679

Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles.

Beata Chertok1, Adam J Cole, Allan E David, Victor C Yang.   

Abstract

Magnetic nanoparticles (MNP) have been widely studied for use in targeted drug delivery. Analysis of MNP biodistribution is essential to evaluating the success of targeting strategies and the potential for off-target toxicity. This work compared the applicability of inductively coupled plasma optical emission spectroscopy (ICP-OES) and electron spin resonance (ESR) spectroscopy in assessing MNP biodistribution. Biodistribution was evaluated in 9L-glioma bearing rats administered with MNP (12-25 mg Fe/kg) under magnetic targeting. Ex vivo analysis of MNP in animal tissues was performed with both ICP-OES and ESR. A cryogenic method was developed to overcome the technical hurdle of loading tissue samples into ESR tubes. Comparison of results from the ICP-OES and ESR measurements revealed two distinct relationships for organs accumulating high or low levels of MNP. In organs with high MNP accumulation such as the liver and spleen, data were strongly correlated (r = 0.97, 0.94 for the liver and spleen, respectively), thus validating the equivalency of the two methods in this high concentration range (>1000 nmol Fe/g tissue). The two sets of measurements, however, differed significantly in organs with lower levels of MNP accumulation such as the brain, kidney, and the tumor. Whereas ESR resolved MNP to 10-55 nmol Fe/g tissue, ICP-OES failed to detect MNP because of masking by endogenous iron. These findings suggest that ESR coupled to cryogenic sample handling is more robust than ICP-OES, attaining better sensitivity in analyses. Such advantages render ESR the method of choice for accurate profiling of MNP biodistribution across tissues with high variability in nanoparticle accumulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20039679      PMCID: PMC2849878          DOI: 10.1021/mp900161h

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  25 in total

1.  Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study.

Authors:  B D Ross; Y J Zhao; E R Neal; L D Stegman; M Ercolani; O Ben-Yoseph; T L Chenevert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

2.  Myocardial tissue preparation for ESR spectroscopy: some methods may cause artifactual generation of signals.

Authors:  S L Shuter; M J Davies; P B Garlick; D J Hearse; T F Slater
Journal:  Free Radic Res Commun       Date:  1990

3.  Biomimetic amplification of nanoparticle homing to tumors.

Authors:  Dmitri Simberg; Tasmia Duza; Ji Ho Park; Markus Essler; Jan Pilch; Lianglin Zhang; Austin M Derfus; Meng Yang; Robert M Hoffman; Sangeeta Bhatia; Michael J Sailor; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

4.  Arterial embolization hyperthermia: hepatic iron particle distribution and its potential determination by magnetic resonance imaging.

Authors:  Paul Moroz; Heath Pardoe; Stephen K Jones; Timothy G St Pierre; Swithin Song; Bruce N Gray
Journal:  Phys Med Biol       Date:  2002-05-07       Impact factor: 3.609

5.  The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma.

Authors:  Andreas Jordan; Regina Scholz; Klaus Maier-Hauff; Frank K H van Landeghem; Norbert Waldoefner; Ulf Teichgraeber; Jens Pinkernelle; Harald Bruhn; Fabian Neumann; Burghard Thiesen; Andreas von Deimling; Roland Felix
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

Review 6.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

Review 7.  Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells.

Authors:  Robert R Crichton; Stéphanie Wilmet; Rachida Legssyer; Roberta J Ward
Journal:  J Inorg Biochem       Date:  2002-07-25       Impact factor: 4.155

8.  Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors.

Authors:  Esben K U Larsen; Thomas Nielsen; Thomas Wittenborn; Henrik Birkedal; Thomas Vorup-Jensen; Mogens H Jakobsen; Leif Ostergaard; Michael R Horsman; Flemming Besenbacher; Kenneth A Howard; Jørgen Kjems
Journal:  ACS Nano       Date:  2009-07-02       Impact factor: 15.881

9.  Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent.

Authors:  Philippe Bourrinet; Howard H Bengele; Bruno Bonnemain; Anne Dencausse; Jean-Marc Idee; Paula M Jacobs; Jerome M Lewis
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

10.  Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells.

Authors:  Jin Xie; Kai Chen; Ha-Young Lee; Chenjie Xu; Andrew R Hsu; Sheng Peng; Xiaoyuan Chen; Shouheng Sun
Journal:  J Am Chem Soc       Date:  2008-05-24       Impact factor: 15.419

View more
  23 in total

1.  Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.

Authors:  Adam J Cole; Allan E David; Jianxin Wang; Craig J Galbán; Hannah L Hill; Victor C Yang
Journal:  Biomaterials       Date:  2010-12-21       Impact factor: 12.479

2.  Size-dependent ferrohydrodynamic relaxometry of magnetic particle imaging tracers in different environments.

Authors:  Hamed Arami; R M Ferguson; Amit P Khandhar; Kannan M Krishnan
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

3.  Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles.

Authors:  Adam J Cole; Allan E David; Jianxin Wang; Craig J Galbán; Victor C Yang
Journal:  Biomaterials       Date:  2011-09       Impact factor: 12.479

4.  Alkaline and ultrasonic dissolution of biological materials for trace silicon determination.

Authors:  Robert D Viveros; Alexander Liberman; William C Trogler; Andrew C Kummel
Journal:  J Vac Sci Technol B Nanotechnol Microelectron       Date:  2015-04-01

Review 5.  Imaging of cells and nanoparticles: implications for drug delivery to the brain.

Authors:  Katica Stojanov; Inge S Zuhorn; Rudi A J O Dierckx; Erik F J de Vries
Journal:  Pharm Res       Date:  2012-07-18       Impact factor: 4.200

6.  The clearance and biodistribution of magnetic composite nanoparticles in healthy and osteoarthritic rat knees.

Authors:  Brittany D Partain; Mythreyi Unni; Carlos Rinaldi; Kyle D Allen
Journal:  J Control Release       Date:  2020-01-28       Impact factor: 9.776

Review 7.  Cancer theranostics: the rise of targeted magnetic nanoparticles.

Authors:  Adam J Cole; Victor C Yang; Allan E David
Journal:  Trends Biotechnol       Date:  2011-04-12       Impact factor: 19.536

Review 8.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

9.  Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography.

Authors:  Beata Chertok; Allan E David; Victor C Yang
Journal:  J Control Release       Date:  2011-07-07       Impact factor: 9.776

Review 10.  Magnetic nanoparticles for tumor imaging and therapy: a so-called theranostic system.

Authors:  Huining He; Allan David; Beata Chertok; Adam Cole; Kyuri Lee; Jian Zhang; Jianxin Wang; Yongzhuo Huang; Victor C Yang
Journal:  Pharm Res       Date:  2013-01-24       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.